SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME
ZYME Stock | USD 12.74 0.66 4.93% |
About 64% of Zymeworks Common's investor base is looking to short. The analysis of the overall investor sentiment regarding Zymeworks Common Stock suggests that many traders are alarmed. The current market sentiment, together with Zymeworks Common's historical and current headlines, can help investors time the market. In addition, many technical investors use Zymeworks Common Stock stock news signals to limit their universe of possible portfolio assets.
Zymeworks |
NEW YORK, April 08, 2024 -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. . Such investors are advised to contact Danielle
Read at benzinga.com
![]() |
Zymeworks Common Stock Current Investor Sentiment
Comfort Level 36
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Zymeworks Common's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Zymeworks Common Stock.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Zymeworks Common Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Zymeworks Common can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zymeworks Common Fundamental Analysis
We analyze Zymeworks Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zymeworks Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zymeworks Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Zymeworks Common is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Zymeworks Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zymeworks Common stock to make a market-neutral strategy. Peer analysis of Zymeworks Common could also be used in its relative valuation, which is a method of valuing Zymeworks Common by comparing valuation metrics with similar companies.
Peers
Zymeworks Common Related Equities
PTGX | Protagonist Therapeutics | 2.42 | ||||
SNDX | Syndax Pharmaceuticals | 1.02 | ||||
APLS | Apellis Pharmaceuticals | 4.33 | ||||
BLUE | Bluebird Bio | 4.90 | ||||
STOK | Stoke Therapeutics | 5.73 | ||||
RVMD | Revolution Medicines | 5.89 | ||||
RLAY | Relay Therapeutics | 6.16 | ||||
ARWR | Arrowhead Pharmaceuticals | 6.35 | ||||
YMAB | Y MAbs | 6.65 | ||||
CYTK | Cytokinetics | 6.76 | ||||
BPMC | Blueprint Medicines | 7.06 | ||||
ZNTL | Zentalis Pharmaceuticals | 7.25 | ||||
AKRO | Akero Therapeutics | 7.29 | ||||
TVTX | Travere Therapeutics | 7.48 | ||||
MRSN | Mersana Therapeutics | 7.69 | ||||
CABA | Cabaletta Bio | 7.73 | ||||
EDIT | Editas Medicine | 7.81 | ||||
TERN | Terns Pharmaceuticals | 8.13 | ||||
PRQR | ProQR Therapeutics | 8.58 | ||||
DAWN | Day One | 8.94 | ||||
INZY | Inozyme Pharma | 9.17 | ||||
ANNX | Annexon | 9.47 | ||||
ALEC | Alector | 14.02 |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |